Nacionalinė farmacijos pramonės asociacija

Company age: 20 y. 6 mo.

Update

Company overview

Company name Nacionalinė farmacijos pramonės asociacija
Company code 300553096
Registered address Kaunas, Pažaislio g. 18, LT-45362
Registration date 2006-03-24 Company age: 20 y. 6 mo.
Phone Phone
Email Email
Website None
Company manager For registered members only Log in
Revenue (2025) 1,200 € +9% History
Profit (2025) -42 € History
Number of employees 0
Managed vehicles 0
Current SODRA debt No debt Read more
Days of debt to SODRA per year 0 days
Current VMI debt No debt Read more
Financial statements Late filing
Legal form Association
NACE activity Market research and public opinion polling
Ownership form Private without foreign capital

Download a detailed company report

Make confident decisions with all the information about Nacionalinė farmacijos pramonės asociacija. In one document, you will find full financial data, risk and potential assessment, and key Scoris insights.

19.99 € + PVM Get report

Description

This description was generated by artificial intelligence.
Nacionaline farmacijos pramones asociacija (company code 300553096) is an operational association registered on 24 March 2006. It is classified as a public entity with the legal form of an association, operating under private ownership. The governance structure is listed as CEO with board/council, and the entity is grouped in the sector of national private non-financial companies. The ownership form indicates that Lithuanian natural and legal persons hold more than 50% of the authorised capital, with no foreign investor capital involved.

The company is based in Kaunas, at Pažaislio g. 18, LT-45362, Kauno m. sav., Kauno apskr. Its stated activity is EVRK code N.73.20.00, market research and public opinion polling. Financial results show very small-scale operations. Revenue was €1.1K in 2023 and 2024, then increased to €1.2K in 2025. The company moved from a net profit of €58 in 2023 to a net loss of €43 in 2024 and €42 in 2025, while equity declined from €149 to €64 over the same period. Revenue growth in 2025 was 9.1% year on year, with a profit margin of -3.5%.